An Early-Stage Biotech Company Empowering Veterans & First-Responders to Thrive
Sōhei is advancing drug development in psychedelic treatments targeting the most prevalent and debilitating neuropsychiatric conditions and progressing proof of concept studies, clinical trials, and FDA-approved studies to incubate innovative treatments.
Why Sōhei?
30+ Years Experience
We have deep experience with innovative molecules and the Veteran population.
10+ Research Publications
We have contributed to 10+ academic research papers on Veterans.
Top Strategic Partnerships
We are affiliated with the top psychedelic research institutes around the world.